Connect Biopharma Holdings annual revenue
2023
2024
2025
Connect Biopharma Holdings Revenue Growth & History (CNTB)
Connect Biopharma Holdings reported $64,000 in revenue for fiscal 2025, a decrease of 99.75% from the previous fiscal year.
View full Connect Biopharma Holdings company overviewConnect Biopharma Holdings annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $64,000 | −$26.0M | −99.75% |
| 2024 | 2024-12-31 | $26.0M | $26.0M | — |
| 2023 | 2023-12-31 | $0 | — | — |
Connect Biopharma Holdings quarterly revenue
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $2.8M | $2.7M | +5666.67% |
| Q1 2026 | 2026-03-31 | $169,000 | $169,000 | — |
| Q4 2025 | 2025-12-31 | $0 | — | — |
| Q3 2025 | 2025-09-30 | $16,000 | −$1.2M | −98.69% |
| Q2 2025 | 2025-06-30 | $48,000 | −$24.1M | −99.80% |
| Q1 2025 | 2025-03-31 | $0 | — | — |
| Q3 2024 | 2024-09-30 | $1.2M | — | — |
| Q2 2024 | 2024-06-30 | $24.1M | — | — |
Connect Biopharma Holdings revenue growth trends
Connect Biopharma Holdings's latest reported quarter, Q2 2026, generated $2.8M in revenue, an increase of 5666.67% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Connect Biopharma Holdings source filings ↗